On 13 June, the US Supreme Court denied the validity of patenting genes (Nature 498, 281-282; 2013) -but this is only part of the story. Since 2010, the court has made three separate landmark rulings that give inventors full access to the wellspring of ideas, laws of nature and natural products.
Patent law requires ingenuity and invention for patenting a discovery. The Supreme Court established in 1980 that genetically modifying cells to eat oil, resist pesticides or produce insulin, for example, was a patentable invention.
After the draft human genome was released in 2001, the US Patent and Trademark Office stipulated that only genes of known function could be patented. Into this category fell BRCA1 and BRCA2, the genes mutated in some breast and ovarian cancers, which were patented by the Utah firm Myriad Genetics. But questions arosehadn't the firm simply extracted a natural product? Did it 'own' the genetic information within?
The court subsequently ruled that a patent that pre-empts all uses of a natural product was disallowed (I was a plaintiff in the case). In separate cases in 2010 and 2012, it also ruled against patents that pre-empt all uses of an abstract idea or of a natural law.
I disagree that these rulings could stifle US innovation: they set a higher bar for genuine invention so that people will gain from better medicines and devices. And they will retain ownership of their genomes. Harry Ostrer Albert Einstein College of Medicine, New York, USA. harry.ostrer@einstein.yu.edu Latin America should ditch impact factors Increased reliance on impact factors to evaluate scientific merit is having negative social and environmental effects in Latin America. We should abandon these indicators and concentrate on strengthening regional and national journals and networks for socially and locally relevant research.
Impact-factor rankings have damaged the region for several reasons. Because impact factors are generally low for conservation and ecology articles (compared with those in, say, biotechnology or medicine), these disciplines attract proportionately less funding. Top-tier journals tend to focus on global environmental issues to boost citation rates, at the expense of regionally important ones. And theoretical-ecology journals have higher impact factors than applied-ecology journals.
Together, these metrics are diverting researchers away from regional problems even as socioecosystems deteriorate around them. The South American biogeographic region comprises 10% of Earth's surface and hosts 50% of its biodiversity, yet the continent contributed less than 4% of global scientific output in 2010 (see go.nature.com/ hudjwn; in Spanish).
We suggest that Latin America should aim to achieve a genuine knowledge dialogue (see go.nature.com/ifrnlx; in Spanish) through confronting regional challenges, rather than focus on increasing its global "brain circulation" (Nature 490, 325; 2012 145-146; 2013) . This has prompted international speculation that China might adopt an absolute cap on national emissions by 2020. We contend that future Chinese climate policy is unlikely to rely mainly on cap and trade, and so will not depend on the success of pilot schemes.
In our view, the schemes are not likely to deliver a carbon price that reflects its social cost or provides an incentive for longterm investment in low-carbon technologies. The government may bring in other instruments in parallel (such as carbon taxes or mandatory emissions standards), which would distort the carbon price in China as they have in Europe.
The Chinese government should not allow the carbon prices emerging from its pilot trading schemes to distract attention from the real costs of moving to a low-carbon economy. 
